PCR and capillary electrophoresis / fragment analysis can be used to rapidly detect NPM1 and FLT3‐ITD (for AML), JAK2 p.V617F, CALR indels, and MPL p.W515 (for MPN) alterations. Here, NPM1 is linked to acute myeloid leukemia.